About the Authors

Alexis-Pierre Bemelmans

Contributed equally to this work with: Alexis-Pierre Bemelmans, Corinne Kostic

Affiliation Unit of Gene Therapy and Stem Cell Biology, Jules Gonin Eye Hospital, Lausanne, Switzerland

Corinne Kostic

Contributed equally to this work with: Alexis-Pierre Bemelmans, Corinne Kostic

Affiliation Unit of Gene Therapy and Stem Cell Biology, Jules Gonin Eye Hospital, Lausanne, Switzerland

Sylvain V Crippa

Affiliation Unit of Gene Therapy and Stem Cell Biology, Jules Gonin Eye Hospital, Lausanne, Switzerland

William W Hauswirth

Affiliation Department of Ophthalmology, University of Florida, Gainesville, Florida, United States of America

Janis Lem

Affiliation Department of Ophthalmology, Program in Genetics and Tufts Center for Vision Research, Tufts University School of Medicine, Boston, Massachusetts, United States of America

Francis L Munier

Affiliation Unit of Clinical Oculogenetics, Jules Gonin Eye Hospital, Lausanne, Switzerland

Mathias W Seeliger

Affiliation Retinal Electrodiagnostics Research Group, Department of Ophthalmology II, Eberhard-Karls University, Tübingen, Germany

Andreas Wenzel

Affiliation Laboratory of Retinal Cell Biology, University Hospital, Zürich, Switzerland

Yvan Arsenijevic

To whom correspondence should be addressed. E-mail: yvan.arsenijevic@ophtal.vd.ch

Affiliation Unit of Gene Therapy and Stem Cell Biology, Jules Gonin Eye Hospital, Lausanne, Switzerland

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

APB, CK, AW, and YA designed the study. APB, CK, SVC, FLM, MWS, AW, and YA analyzed the data. APB, CK, FLM, AW, and YA contributed to writing the paper. WWH provided the R0.8 promoter used. JL created the Gnat1−/− transgenic mouse models used in the study.